The London Stock Exchange has seen several of its companies decamp for Wall Street and SPACs have become a new avenue for those companies to skip across the pond.
This week, we speak with Hervé Tessler, CEO of Noventiq (LSE:NVNQ) and Jerry Letter, CFO and COO of Corner Growth Acquisition Corp.
They explain why they think Noventiq will be better valued on the Nasdaq following the close of their $800 million combination announced in May, and how Noventiq’s own operations as a digital transformation facilitator are ramping up in the developing world.
Give it a listen.
Terms Tracker for the Week Ending January 3, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Thanks to both the Christmas and New Year’s holidays falling mid-week this year, it feels like markets have been treading water for a full two...
NewHold Investment Corp. III (NASDAQ:NHICU) has filed to return another repeat SPAC team to the mix aboard a $175 million vehicle that will be scanning the market for attractive technology targets. The new SPAC has some characteristics of a re-do, as it bears similar terms to the team’s last SPAC, NewHold II, which IPO’d in...
At the SPAC of Dawn While the SPAC market has yet to see the first new deal of 2025, we will see the first 2025 de-SPAC make its debut on the Nasdaq later today as Mars (NASDAQ:MARX) successfully closed its combination with security technology firm ScanTech (NASDAQ:STAI). This starts the year off small as the...
December 2024 corporate actions continues the trend of SPAC teams seeking additional extensions beyond their third round, as they work to close their combinations with the remaining funds after redemptions. Despite this activity, both announcements and corporate actions associated with completion votes were notably few this month. Extension Votes In December, there were 26 scheduled...
At the SPAC of Dawn 2025 dawns with a reminder to SPAC teams that, as the Rolling Stones song goes, “You can’t always get what you want.” That was the message sent by Aimei Health I (NASDAQ:AFJK) shareholders as they rejected a proposal to reduce the SPAC’s monthly contribution to trust for the duration of...